Study Uses Medicare Claims to Link Physician Beliefs About Benzodiazipene Safety and Prescription Fills What should readers take away from your report?

Response: Because this was a small pilot study, the main take-home from this report is really about the method that we used–we used prescribing behavior as determined from Medicare Part D prescription claim data–and selected clinicians for a survey on the basis of their actual prescribing behavior and not just what they said about their prescribing. What recommendations do you have for future research as a result of this study?

Response: This demonstrates the potential of a new method to understand clinician decision-making, where you can link up clinician surveys with objective evidence of behavior from insurance claims or other kinds of administrative data.

Maust DT, Lin LA, Candon M, Strominger J, Marcus SC. Linking a Survey of Clinician Benzodiazepine-Related Beliefs to Risk of Benzodiazepine Prescription Fills Among Patients in Medicare. Ann Fam Med. 2022 Nov-Dec;20(6):556-558. doi: 10.1370/afm.2883. PMID: 36443088.

The information on is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

Last Updated on November 30, 2022 by